StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
OACCOaktree Acquisition Corp. III Life Sciences
stockpulse.co.kr
Nasdaq
$10.65▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $261.8MShares out 24.6M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

8
  • 1d agoAfter-hours26.10.24 05:30
    4Ownership#●●●

    Oaktree Acquisition Corp. III Life Sciences

    Oaktree Capital Management and its affiliates have filed a Form 4 to report changes in their beneficial ownership of Oaktree Acquisition Corp. III Life Sciences. This filing discloses updates to the equity holdings of insiders and major shareholders.…more

    $10.65+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 10.16Pre-market26.10.16 19:07
    DEFA14AOther

    Oaktree Acquisition Corp. III Life Sciences

    Oaktree Acquisition Corp. III Life Sciences has postponed its extraordinary general meeting to extend the deadline for an initial business combination from October 16, 2026, to October 23, 2026. This postponement is intended to allow for further solicitation of proxies, and previously submitted proxies will remain valid for the rescheduled meeting unless revoked.…more

    $10.65+0.00%vs prev close
    View filingShare
  • 10.16Pre-market26.10.16 19:04
    8-KKey event

    Oaktree Acquisition Corp. III Life Sciences

    Oaktree Acquisition Corp. III Life Sciences has postponed its extraordinary general meeting to consider extending the deadline for an initial business combination from October 16, 2026, to October 23, 2026. The postponement is intended to allow for further solicitation of proxies, and previously submitted proxies remain valid unless revoked.…more

    $10.65+0.00%vs prev close
    View filingShare

7 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire

No news collected yet. New articles will appear here.